Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
A drug called AV650 (tolperisone HCl) will be given to patients who have spasticity
associated with multiple sclerosis. This study has three purposes:
1. To determine whether AV650 is safe for patients with multiple sclerosis;
2. To gather some early evidence as to whether AV650 is effective in treating spasticity in
patients with multiple sclerosis; and,
3. To assess what the body does with AV650 once it is ingested (Germany and Czech Republic
sites only).